Revaccination With Pneumococcal Conjugate Vaccine - Characterization of the Immune Response After Polysaccharide.
Phase of Trial: Phase III
Latest Information Update: 30 Nov 2013
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms REPLAY
- Sponsors Wyeth
- 08 Dec 2010 Actual end date changed from Dec 2009 to Aug 2010 as reported by ClinicalTrials.gov.
- 05 Mar 2010 Actual number of patients (90) added as reported by ClinicalTrials.gov.
- 05 Mar 2010 Actual end date (1 Dec 2009) added as reported by ClinicalTrials.gov record.